Changing Paradigms in GI Oncology: Focus on HCC, CRC, and the Broader GI Landscape

This Industry-Sponsored Symposium Is a Medical Education Activity That Is Organized and Funded by the Medical Department of Bristol Myers Squibb.

In this symposium, Ian Chau, Heinz-Josef Lenz, and Arndt Vogel shared insights on the changing paradigm across gastrointestinal (GI) oncology, with a focus on hepatocellular carcinoma (HCC) and colorectal cancer (CRC).

They also discussed the current approaches for HCC management, application of MSI-H/dMMR CRC treatment in clinical practice, and the latest advances shaping the future of GI cancer care.

1. Royal Marsden Hospital and The Institute of Cancer Research, London, UK
2. J Terrence Lanni Chair of Cancer Research, USC Norris Comprehensive Cancer Center, Los Angeles, California, USA
3. University of Toronto Division of Gastroenterology and Hepatology Toronto General Hospital, Princess Margaret Cancer Centre, Toronto, Canada

ONC-DE-2500092